National Heart, Lung, and Blood Institute; Notice of Closed Meeting

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

September 20, 2024

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 89 Issue 183 (Friday, September 20, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 183 (Friday, September 20, 2024)]
[Notices]
[Page 77165]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-21590]



[[Page 77165]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Heart, Lung, and Blood Initial Review Group, 
NHLBI Mentored Clinical and Basic Science Study Section.
    Date: October 31-November 1, 2024.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Bethesdan Hotel, Tapestry Collection by Hilton, 8120 
Wisconsin Avenue, Bethesda, MD 20814, (Hybrid Meeting).
    Contact Person: Manoj Kumar Valiyaveettil, Ph.D., Scientific 
Review Officer, Office of Scientific Review/DERA National Heart, 
Lung, and Blood Institute, National Institutes of Health, 6705 
Rockledge Drive, Room 208-R, Bethesda, MD 20817, (301) 402-1616, 
email: <a href="/cdn-cgi/l/email-protection#8de0ece3e2e7a3fbece1e4f4ecfbe8e8f9f9e4e1cde3e4e5a3eae2fb"><span class="__cf_email__" data-cfemail="3459555a5b5e1a4255585d4d5542515140405d58745a5d5c1a535b42">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: September 17, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-21590 Filed 9-19-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on September 20, 2024.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.